Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | DHFR | P00374 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6424960 | 0.79 | KDM4E (0.34) | KDM4EALDH1A1LMNADHFR | |
| SCHEMBL1766002 | 0.79 | ADORA2A (0.33) | — | |
| SCHEMBL94822 | 0.76 | — | — | |
| SCHEMBL9465286 | 0.72 | AKR1B1 (0.31) | DHFR | |
| SCHEMBL3916442 | 0.72 | ADORA1 (0.30) | — | |
| SCHEMBL8216344 | 0.68 | ADORA3 (0.35) | ALDH1A1 | |
| SCHEMBL1898084 | 0.68 | NUDT1 (0.41) | KDM4EALDH1A1LMNA | |
| SCHEMBL2938699 | 0.64 | PDPK1 (0.37) | KDM4EALDH1A1LMNADHFR | |
| SCHEMBL159447 | 0.64 | KDM4E (0.53) | KDM4EALDH1A1LMNA | |
| SCHEMBL2953678 | 0.63 | ADORA3 (0.38) | ALDH1A1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220273689-A1 | POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2022-09-01 | — | — | US | claimed |
| WO-2021007283-A1 | POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2021-01-14 | — | — | WO | claimed |
| EP-2177606-A2 | N-deoxyribosyltransferases from lactobacillus, corresponding nucleotide sequences and their applications | INSTITUT PASTEUR (FR) | 2010-04-21 | — | — | EP | claimed |
| EP-1427819-B1 | LACTOBACILLUS N-DEOXYRIBOSYL TRANSFERASES, CORRESPONDING NUCLEOTIDE SEQUENCES AND THEIR USES | PASTEUR INSTITUT (FR) | 2009-12-23 | — | — | EP | claimed |
| US-20080280329-A1 | Enzymatic synthesis of deoxyribonucleosides | TISCHER WILHELM | 2008-11-13 | — | — | US | claimed |
| US-20080250513-A1 | LACTOBACILLUS N-DEOXYRIBOSYL TRANSFERASES, CORRESPONDING NUCLEOTIDE SEQUENCES AND THEIR USES | INSTITUT PASTEUR (FR) | 2008-10-09 | — | — | US | claimed |
| CN-101217999-A | Personal care compositions and methods for the beautification of mammalian skin and hair | PROCTER & GAMBLE (US) | 2008-07-09 | — | — | CN | claimed |
| EP-1901817-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | The Procter and Gamble Company (US) | 2008-03-26 | — | — | EP | claimed |
| WO-2007007255-A2 | PERSONAL CARE COMPOSITIONS AND METHODS FOR THE BEAUTIFICATION OF MAMMALIAN SKIN AND HAIR | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-18 | — | — | WO | claimed |
| US-20070009474-A1 | Personal care compositions and methods for the beautification of mammalian skin and hair | THE PROCTER & GAMBLE COMPANY | 2007-01-11 | — | — | US | claimed |
| US-20060068473-A1 | Lactobacillus N-deoxyribosyl transferases, corresponding nucleotide sequences and their uses | INSTITUT PASTEUR (FR) | 2006-03-30 | — | — | US | claimed |
| EP-1206551-A2 | ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOSIDES | Roche Diagnostics GmbH (DE) | 2002-05-22 | — | — | EP | claimed |
| WO-2001014566-A2 | ENZYMATIC SYNTHESIS OF DEOXYRIBONUCLEOSIDES | ROCHE DIAGNOSTICS GMBH (DE) | 2001-03-01 | — | — | WO | claimed |
| US-12583932-B2 | CD38 and ICAM1 antibodies and uses thereof | VIRTUOSO BINCO, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| EP-2498772-B1 | COMPOSITION AND METHODS FOR IMPROVING SKIN APPEARANCE | SYTHEON LTD (US) | 2025-07-30 | — | — | EP | disclosed |
| US-12054768-B2 | Methods for detecting agglutination and compositions for use in practicing the same | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-08-06 | — | — | US | disclosed |
| US-4766110-A | INHIBITS ANGIOTENSIN CONVERTING ENZYME, HYPOTENSIVE AGENTS | RYAN JAMES W (US) | 1988-08-23 | — | — | US | disclosed |
| US-4720459-A | Myelomas for producing human/human hybridomas | MEDICAL COLLEGE OF WISCONSIN RESEARCH FOUNDATION, INC. (US) | 1988-01-19 | — | — | US | disclosed |
| EP-0073143-B1 | NOVEL COMPLEX AMIDO AND IMIDO DERIVATIVES OF CARBOXYALKYL PEPTIDES AND THIOETHERS AND ETHERS OF PEPTIDES | Ryan, James Walter (US) | 1985-11-21 | — | — | EP | disclosed |
| EP-0073143-A2 | Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides | Ryan, James Walter (US) | 1983-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273689-A1 | POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY | NSUN3, NSUN2, RNMT | KDM4E 3366/4885ALDH1A1 2235/4885LMNA 2816/4885 |
| US-12583932-B2 | CD38 and ICAM1 antibodies and uses thereof | FCGR2A, FCGR3B, FCGR1A | KDM4E 3002/4885ALDH1A1 902/4885LMNA 1047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.